United States · Resolution · HCONRES
H.Con.Res. 42 (117th)
Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.
Introduced
21 July 2021
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
This concurrent resolution expresses the sense of Congress that government entities should consider using a portion of proceeds from litigation against opioid manufacturers and distributors for drug take-back programs.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 21 July 2021
Introduced in House (PDF)
Introduced in House · EN · 21 July 2021
Introduced in House
summary · EN · 21 July 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-concurrent-resolution/42
- Open data entity: https://api.congress.gov/v3/bill/117/hconres/42